Company Overview of Blend Therapeutics, Inc.
Blend Therapeutics, Inc. offers drug discovery and development services. It focuses on cancer therapies and drugs development. The company was formerly known as Blend Biosciences, Inc. Blend Therapeutics, Inc. was founded in 2011 and is based in Watertown, Massachusetts.
134 Coolidge Avenue
Watertown, MA 02472
Founded in 2011
Key Executives for Blend Therapeutics, Inc.
Chief Executive Officer, President and Director
Founder, Chairman of The Board and Member of Scientific Advisory Board
Founder, Director and Member of Scientific Advisory Board
Founder and Chairman of Scientific Advisory Board
Compensation as of Fiscal Year 2015.
Blend Therapeutics, Inc. Key Developments
Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
Apr 13 15
Blend Therapeutics, Inc. appointed Drew Fromkin as President and Chief Executive Officer and a member of the company’s Board of Directors. Mr. Fromkin previously served as President and Chief Executive Officer of Clinical Data, Inc. He is an accomplished, global healthcare leader with more than 25 years of experience leading private and public life sciences and healthcare services companies through all stages of growth, including product development and commercial operations. Mr. Fromkin takes on the role of CEO at a pivotal time when Blend is positioned to rapidly advance its novel pipeline of innovative anti-cancer therapeutics into human clinical trials in a variety of cancers. He will lead the company in its plans to file two Investigational New Drug (IND) applications with the U.S. Food and Drug Administration, respectively, in second quarter 2015 for its novel personalized cisplatin prodrug, BTP-114, and in early 2016 for its first targeted drug candidate from its proprietary Pentarin™ platform, BTP-277. BTP-114.
Blend Therapeutics, Inc. Appoints Dennis A. Ausiello, MD to Board of Directors
Jan 7 15
Blend Therapeutics, Inc. announced that it has appointed Dennis A. Ausiello, MD, to the company’s board of directors. As Physician-in-Chief, Emeritus at Massachusetts General Hospital (MGH), Dr. Ausiello. He is currently the Jackson Distinguished Professor of Clinical Medicine at Harvard Medical School and Director of the Center for Assessment Technology and Continuous Health (CATCH).
Blend Therapeutics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 02:45 PM
Dec 18 14
Blend Therapeutics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 02:45 PM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|